הבדלים בין גרסאות בדף "כולסטג'ל - Cholestagel"
מתוך ויקירפואה
שורה 10: | שורה 10: | ||
|התוויות=Cholestagel co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in LDL-cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone. Cholestagel as monotherapy is indicated as adjunctive therapy to diet for teduction of elevated total and LDL- cholesterol in patients with isolated primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated | |התוויות=Cholestagel co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in LDL-cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone. Cholestagel as monotherapy is indicated as adjunctive therapy to diet for teduction of elevated total and LDL- cholesterol in patients with isolated primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated | ||
|קיים גם בתכשירים= | |קיים גם בתכשירים= | ||
− | |שם יצרן=[[GENZYME IRELAND | + | |שם יצרן=[[GENZYME IRELAND]] LTD |
− | |שם בעל הרישום=[[SANOFI - AVENTIS ISRAEL LTD | + | |שם בעל הרישום=[[SANOFI - AVENTIS]] ISRAEL LTD |
|עלון לרופא= | |עלון לרופא= | ||
|עלון לצרכן= | |עלון לצרכן= | ||
שורה 35: | שורה 35: | ||
[[קטגוריה: תרופות]] | [[קטגוריה: תרופות]] | ||
− | [[קטגוריה:שם בעל הרישום SANOFI - AVENTIS | + | [[קטגוריה:שם בעל הרישום SANOFI - AVENTIS]] |
− | [[קטגוריה: שם יצרן GENZYME IRELAND | + | [[קטגוריה: שם יצרן GENZYME IRELAND]] |
[[קטגוריה: ATC first level - C]] | [[קטגוריה: ATC first level - C]] | ||
[[קטגוריה: ATC second level C10]] | [[קטגוריה: ATC second level C10]] | ||
[[קטגוריה: ATC third level C10A]] | [[קטגוריה: ATC third level C10A]] | ||
[[קטגוריה: ATC fourth level C10AC]] | [[קטגוריה: ATC fourth level C10AC]] |
גרסה מ־14:48, 27 ביולי 2013
כולסטג'ל - Cholestagel | ||
---|---|---|
מרכיב פעיל | COLESEVELAM HYDROCHLORIDE | |
קבוצה פרמקולוגית (ATC) | "C10AC = BILE ACID SEQUESTRANTS" | |
שם התרופה | "כולסטג'ל®" (קישור לדף התרופה במאגר משרד הבריאות) |
|
סל הבריאות | לא כלול | |
התוויות |
Cholestagel co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in LDL-cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone. Cholestagel as monotherapy is indicated as adjunctive therapy to diet for teduction of elevated total and LDL- cholesterol in patients with isolated primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated
| |
שם יצרן | GENZYME IRELAND LTD | |
שם בעל הרישום | SANOFI - AVENTIS ISRAEL LTD | |
מינונים | 625MG | |